Adjuvia Therapeutics Begins Phase 1 Trial of ATI-105 for Friedreich’s Ataxia

Adjuvia Therapeutics says it has initiated a Phase 1 clinical trial of ATI-105 for Friedreich’s ataxia. The company also announced the appointment of a Stanford mitochondrial disease expert to its Scientific and Cl…